PMV Pharma issues warrants to buy 41,955,000 shares in $50.8 million offering

Reuters2026/09/01 03:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

PMV Pharmaceuticals priced a $50.8 million public offering featuring accompanying warrants to buy 41,955,000 common shares.
Accompanying warrants carry an initial exercise price of $1.21 per share, immediately exercisable, expiring five years from issuance.
Offering includes 22,055,000 common shares, pre-funded warrants for up to 19,900,000 shares, each sold with one accompanying warrant.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PMV Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608312303PRIMZONEFULLFEED9819184) on September 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

PMV Pharma issues warrants to buy 41,955,000 shares in $50.8 million offering

You may also like

Crypto prices